ABEJA Trademark

Trademark Overview


On Tuesday, August 4, 2020, a trademark application was filed for ABEJA with the United States Patent and Trademark Office. The USPTO has given the ABEJA trademark a serial number of 90092806. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Saturday, June 26, 2021. This trademark is owned by Vir Biotechnology, Inc.. The ABEJA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, proteins, antibodies, and large molecules for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system related diseases and disorders, and infectious diseases, blood disorders, obesity, and cognitive disorders; none of the foregoing including external use pain reliever preparations, ointments, and liniments

Medical research and scientific research information in the field of the production of proteins, antibodies, and large molecules; none of the foregoing relating to external use pain reliever preparations, ointments, and liniments
abeja

General Information


Serial Number90092806
Word MarkABEJA
Filing DateTuesday, August 4, 2020
Status645 - FINAL REFUSAL - MAILED
Status DateSaturday, June 26, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, proteins, antibodies, and large molecules for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system related diseases and disorders, and infectious diseases, blood disorders, obesity, and cognitive disorders; none of the foregoing including external use pain reliever preparations, ointments, and liniments
Goods and ServicesMedical research and scientific research information in the field of the production of proteins, antibodies, and large molecules; none of the foregoing relating to external use pain reliever preparations, ointments, and liniments
Translation of Words in MarkThe English translation of ABEJA in the mark is BEE.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 3, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVir Biotechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events


Event DateEvent Description
Saturday, June 26, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, June 26, 2021FINAL REFUSAL E-MAILED
Saturday, June 26, 2021FINAL REFUSAL WRITTEN
Tuesday, May 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 25, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 25, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 25, 2020NON-FINAL ACTION E-MAILED
Wednesday, November 25, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 24, 2020ASSIGNED TO EXAMINER
Thursday, September 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 7, 2020NEW APPLICATION ENTERED IN TRAM